🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
13/06/2011 0,3626 USD
11/03/2011 0,3626 USD
13/12/2010 0,3626 USD
13/09/2010 0,3626 USD
11/06/2010 0,3626 USD
11/03/2010 0,3626 USD
11/12/2009 0,3626 USD
02/09/2009 0,3626 USD
04/06/2009 0,3626 USD
04/03/2009 0,3626 USD
03/12/2008 0,3626 USD
03/09/2008 0,3626 USD
04/06/2008 0,3626 USD
05/03/2008 0,3626 USD
05/12/2007 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/04/2006 32,11 32,44 32,11 32,39 +0,27% 1,04% 5.800.680
12/04/2006 32,35 32,47 32,08 32,30 -0,62% 1,21% 8.648.410
11/04/2006 32,84 33,49 32,24 32,50 -1,05% 3,81% 14.049.488
10/04/2006 32,83 33,20 32,78 32,84 -0,15% 1,28% 7.959.560
07/04/2006 32,92 33,20 32,73 32,89 -1,06% 1,42% 11.584.697
06/04/2006 33,03 33,44 32,69 33,24 -3,20% 2,25% 22.055.370
05/04/2006 33,76 34,44 33,74 34,34 +1,44% 2,06% 9.332.126
04/04/2006 34,11 34,26 33,79 33,86 +0,20% 1,37% 9.501.063
03/04/2006 33,85 33,98 33,69 33,79 +0,51% 0,85% 10.496.663
31/03/2006 34,13 34,27 33,43 33,62 -1,07% 2,49% 9.235.605
30/03/2006 34,08 34,48 33,61 33,98 -0,53% 2,58% 7.737.908
29/03/2006 34,09 34,43 33,93 34,16 +0,42% 1,46% 8.603.346
28/03/2006 34,39 34,49 33,88 34,02 -1,03% 1,78% 6.691.899
27/03/2006 34,27 34,59 34,16 34,37 -0,08% 1,25% 6.115.709
24/03/2006 34,47 34,66 34,35 34,40 -0,41% 0,89% 5.343.438
23/03/2006 34,45 34,83 34,27 34,54 -0,08% 1,63% 5.766.515
22/03/2006 33,92 34,66 33,92 34,57 +0,95% 2,17% 6.512.482
21/03/2006 34,22 34,52 34,01 34,25 +0,65% 1,51% 7.741.786
20/03/2006 33,91 34,28 33,80 34,03 +0,06% 1,44% 5.920.676
17/03/2006 33,85 34,06 33,73 34,01 +1,02% 0,96% 9.162.978
16/03/2006 33,40 33,88 33,36 33,66 +0,34% 1,57% 6.463.121
15/03/2006 33,40 33,65 33,28 33,55 +0,17% 1,11% 5.364.922
14/03/2006 33,49 33,84 33,35 33,49 -0,28% 1,45% 6.189.802
13/03/2006 33,19 33,73 33,16 33,59 +1,27% 1,73% 8.544.554
10/03/2006 33,16 33,36 32,92 33,17 +0,72% 1,32% 6.199.130
09/03/2006 32,99 33,06 32,81 32,93 -0,49% 0,75% 5.366.074
08/03/2006 33,02 33,25 32,77 33,09 -0,63% 1,47% 5.991.416
07/03/2006 33,36 33,40 33,09 33,30 -0,17% 0,92% 5.778.777
06/03/2006 33,50 33,73 33,21 33,36 -0,65% 1,57% 8.396.995
03/03/2006 33,34 33,80 33,16 33,58 +0,20% 1,92% 6.932.939